285 related articles for article (PubMed ID: 23827542)
21. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
[TBL] [Abstract][Full Text] [Related]
22. Surface grafting of cellulose nanocrystals with poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
Yu HY; Qin ZY
Carbohydr Polym; 2014 Jan; 101():471-8. PubMed ID: 24299800
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles.
Rytting E; Bur M; Cartier R; Bouyssou T; Wang X; Krüger M; Lehr CM; Kissel T
J Control Release; 2010 Jan; 141(1):101-7. PubMed ID: 19720096
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
[TBL] [Abstract][Full Text] [Related]
26. Effect of emulsification-diffusion parameters on the formation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) particles.
Göz E; Karakeçili A
Artif Cells Nanomed Biotechnol; 2016; 44(1):226-34. PubMed ID: 25058033
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
28. Development of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fibers for skin tissue engineering: effects of topography, mechanical, and chemical stimuli.
Kuppan P; Vasanthan KS; Sundaramurthi D; Krishnan UM; Sethuraman S
Biomacromolecules; 2011 Sep; 12(9):3156-65. PubMed ID: 21800891
[TBL] [Abstract][Full Text] [Related]
29. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
[TBL] [Abstract][Full Text] [Related]
30. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
31. Production and characterization of poly(3-hydroxy butyrate-co-3 hydroxyvalerate) (PHBV) by a novel halotolerant mangrove isolate.
Moorkoth D; Nampoothiri KM
Bioresour Technol; 2016 Feb; 201():253-60. PubMed ID: 26684174
[TBL] [Abstract][Full Text] [Related]
32. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: Optimization, pharmacokinetic, cytotoxicity and in vivo assessments.
Vardhan H; Mittal P; Adena SKR; Upadhyay M; Mishra B
Int J Biol Macromol; 2017 Oct; 103():791-801. PubMed ID: 28536023
[TBL] [Abstract][Full Text] [Related]
33. Poly(ɛ-caprolactone) composites reinforced by biodegradable poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fiber.
Ju D; Han L; Li F; Chen S; Dong L
Int J Biol Macromol; 2014 Jun; 67():343-50. PubMed ID: 24704167
[TBL] [Abstract][Full Text] [Related]
34. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.
Wang T; Li M; Gao H; Wu Y
J Colloid Interface Sci; 2011 Jan; 353(1):107-15. PubMed ID: 20947092
[TBL] [Abstract][Full Text] [Related]
36. Thermo-mechanical properties of the composite made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and acetylated chitin nanocrystals.
Wang B; Li J; Zhang J; Li H; Chen P; Gu Q; Wang Z
Carbohydr Polym; 2013 Jun; 95(1):100-6. PubMed ID: 23618245
[TBL] [Abstract][Full Text] [Related]
37. Application of Artificial Neural Networks in the Design and Optimization of a Nanoparticulate Fingolimod Delivery System Based on Biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate).
Shahsavari S; Rezaie Shirmard L; Amini M; Abedin Dokoosh F
J Pharm Sci; 2017 Jan; 106(1):176-182. PubMed ID: 27666377
[TBL] [Abstract][Full Text] [Related]
38. Sequence distribution in microbial poly(3-hydroxybutyrate-co-3-hydroxyvalerate) co-polyesters determined by NMR and MS.
Zagar E; Krzan A; Adamus G; Kowalczuk M
Biomacromolecules; 2006 Jul; 7(7):2210-6. PubMed ID: 16827589
[TBL] [Abstract][Full Text] [Related]
39. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.
Radu IC; Hudita A; Zaharia C; Galateanu B; Iovu H; Tanasa EV; Georgiana Nitu S; Ginghina O; Negrei C; Tsatsakis A; Velonia K; Shtilman M; Costache M
Drug Deliv; 2019 Dec; 26(1):318-327. PubMed ID: 30896267
[TBL] [Abstract][Full Text] [Related]
40. Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis.
Bawa R; Fung SY; Shiozaki A; Yang H; Zheng G; Keshavjee S; Liu M
Nanomedicine; 2012 Jul; 8(5):647-54. PubMed ID: 21889478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
